I direct and support operations, strategic planning, and execution of more than 40 research projects per year in collaboration with our commercial partners, driving innovation across the pharmacological and biotechnology sectors. Highlights:-Championed the efforts of my colleagues by promoting studies in immunology through publications and conference engagements, positioning the company on the cutting-edge for research into ulcerative colitis and Crohn’s disease. -Authored and reviewed highly technical scientific protocols used both internally and externally, ensuring alignment with the needs of our clients seeking complex and nonstandard assays. -Collaborated with R&D on the validation of a primary human colonic epithelial cell organ-on-a-chip system derived from intestinal PSCs to use for toxicology, DMPK, and immunological research applications.-Managed the full product lifecycle and market launch of a gut-specific immunology assay for anti-inflammatory drug screening. -Advised leadership teams on potential partnership opportunities and technical upgrades to our laboratory and research capabilities, as well as enabled data-driven decision-making through monthly reporting.

In this role, I nurtured relationships with our industry partners in the pharma and biotech spaces, communicating research studies, project proposals, and findings across the toxicology, immunology, DMPK, and pharmacology therapeutic areas. Highlights:-Identified and implemented process improvements and templates that improved project times by 50%.-Enhanced our pricing accuracy and improved the consistency of quotes through the development and rollout of a modular pricing matrix and custom pricing calculators. -Coached and mentored junior staff and fostered a culture of knowledge-sharing, resulting in a retention rate of more than 80%.-Led efforts to secure state-of-the-art tools and technologies for our research teams and trained staff in their utilization.

In this position, I provided emergency medical care to individuals across the region who required immediate and urgent treatment. I acted as the scene command and point of contact to law enforcement, healthcare providers, hospital staff, and other stakeholders. I also secured new equipment through grant submissions and grant funding.

In this position, I managed operations of up to three full ambulance crews and served as senior decision maker for all technical and medical operations.

In this role, I contributed as a board member, overseeing various aspects of the company, including financial management, operations, and organizational governance.

In this role, I served as the line officer for technical and medical operations. I wa responsible for supply management for the organization, as well as bugiting and forecasting supply usage based on historical call volumes.

During this time, I led the design and execution of several research projects in immunology and molecular biology. Highlights:-Spearheaded an initiative to secure a T32 training grant from NIH for STI/HIV research. -Utilized biomedical engineering techniques to study and characterize STI pathogenesis, resulting in the development and characterization of a primary human Fallopian tube epithelial organ-on-a-chip model.-Partnered with the laboratory at North Carolina State University of the adaptation of a human Fallopian tube model MPS for primary porcine oviduct epithelial cells. -Spearheaded two thesis projects, both resulting in first author publications.